What if physicians could offer patients access to a potentially life-preserving test, but could not easily identify which of their patients were eligible?
That is the exact situation many providers have found themselves in since Medicare announced it would begin covering lung cancer screening for patients meeting a certain set of criteria.
In a decision memo published February, 2015, CMS agreed to make Medicare coverage available for a low dose computed tomography (LDCT) lung cancer screening for eligible patients. Patients who are between ages 55 and 77, asymptomatic, are either a current smoker or have quit within the last 15 years, and, have a tobacco smoking history of at least 30 pack-years can now qualify for an annual preventative screening.
CMS added the coverage after determining there was sufficient evidence that LDCT procedures were cost-effective for high risk populations. A study by the National Lung Cancer Screening Trial, for example, found that 12,000 deaths a year could be avoided if high-risk patients underwent a LDCT scan. Lung cancer is currently the leading cause of cancer-related death among both men and women in the US.